Bml Capital Management, LLC Portfolio Holdings

Bml Capital Management, LLC

  • $149 Billion
  • Q1 2024

Bml Capital Management, LLC has filed its 13F form on April 23, 2024 for Q1 2024 where it was disclosed a total value porftolio of $149 Billion distributed in 30 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Ishares Trishares 0 3 Mnth Tre with a value of $27.2B, Atea Pharmaceuticals, Inc. with a value of $22.4B, Spdr Bloomberg 1 3 Month T Bil with a value of $18.4B, Adverum Biotechnologies Inc with a value of $11.8B, and Aclaris Therapeutics, Inc. with a value of $11.7B.

Examining the 13F form we can see an increase of $17.3B in the current position value, from $132B to 149B.

Bml Capital Management, LLC is based out at Zionsville, IN

Below you can find more details about Bml Capital Management, LLC portfolio as well as his latest detailed transactions.

Portfolio value $149 Billion
Healthcare: $80.8 Billion
ETFs: $45.6 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$0
$27.2 Billion 18.21% of portfolio
270,000
Q3 2023 Added 50.0%
$330M
$22.4 Billion 14.98% of portfolio
5,536,710
Q1 2024 Added 1.37%
$0
$18.4 Billion 12.29% of portfolio
200,000
Q1 2023 Added 100.0%
Adverum Biotechnologies Inc
-
$11.8 Billion 7.89% of portfolio
-
Q1 2024 New
$90.7M
$11.7 Billion 7.8% of portfolio
9,395,934
Q1 2024 Added 1,338.65%
$107M
$11 Billion 7.36% of portfolio
3,654,053
Q1 2024 Added 12.43%
$270M
$6.01 Billion 4.02% of portfolio
2,193,742
Q1 2024 Added 0.63%
$53.4M
$5.12 Billion 3.43% of portfolio
4,001,627
Q3 2023 Added 1,461.45%
Instil Bio Inc
-
$3.77 Billion 2.52% of portfolio
-
Q1 2024 New
$42.6M
$3.62 Billion 2.42% of portfolio
2,177,913
Q1 2024 Added 65.72%
$87.5M
$3.59 Billion 2.4% of portfolio
2,061,338
Q1 2024 Reduced -0.0%
$208M
$3.54 Billion 2.37% of portfolio
879,478
Q1 2024 Reduced 14.57%
$74.1M
$2.47 Billion 1.65% of portfolio
900,000
Q1 2024 Reduced 38.12%
$91.2M
$2.47 Billion 1.65% of portfolio
844,496
Q1 2024 Reduced 33.06%
$90.8M
$2.22 Billion 1.49% of portfolio
1,306,490
Q1 2024 New
Astrotech Corp
-
$1.97 Billion 1.32% of portfolio
-
Q4 2022 New
$0
$1.33 Billion 0.89% of portfolio
498,851
Q1 2024 Added 6.54%
$47M
$1.24 Billion 0.83% of portfolio
706,930
Q1 2023 Reduced 17.63%
$14.4M
$1.23 Billion 0.82% of portfolio
1,761,702
Q3 2023 Added 1.53%
$50.7M
$1.09 Billion 0.73% of portfolio
606,145
Q1 2024 Added 37.03%
$298M
$1.07 Billion 0.71% of portfolio
180,000
Q4 2023 Added 20.0%
-
$888 Million 0.59% of portfolio
-
Q1 2024 Added 5.5%
Enliven Therapeutics Inc
-
$881 Million 0.59% of portfolio
-
Q1 2024 Added 0.2%
Vistagen Therapeutics Inc
-
$792 Million 0.53% of portfolio
-
Q4 2023 Added 50.0%
$42.5M
$683 Million 0.46% of portfolio
306,465
Q1 2023 New
Calcimedica Inc
-
$667 Million 0.45% of portfolio
-
Q1 2024 Added 10.31%
Q32 Bio Inc
-
$424 Million 0.28% of portfolio
-
Q1 2024 New
Talis Biomedical Corp
-
$374 Million 0.25% of portfolio
-
Q4 2023 New
$74.5M
$151 Million 0.1% of portfolio
200,464
Q1 2024 New

Summary

  • Portfolio
  • No. of Stocks 30
  • Current Value $149 Billion
  • Prior Value $132 Billion
  • Filing
  • Period Q1 2024
  • Filing Date April 23, 2024
  • Form Type 13F-HR
  • Activity in Q1 2024
  • New Purchases 6 stocks
  • Additional Purchases 10 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 4 stocks
Track This Portfolio

Track Bml Capital Management, LLC Portfolio

Follow Bml Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bml Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bml Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email